"Small cell cancer" trang 1 - tải miễn phí từ tailieunhanh
Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells

Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells
16    63    1
Long noncoding RNA POU3F3 enhances cancer cell proliferation, migration and invasion in non-small cell lung cancer (adenocarcinoma) by downregulating microRNA-30d-5p

Long noncoding RNA POU3F3 enhances cancer cell proliferation, migration and invasion in non-small cell lung cancer (adenocarcinoma) by downregulating microRNA-30d-5p
8    41    1
TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location

TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location
10    57    1
Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: Associations with environmental factors and clinical outcomes

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: Associations with environmental factors and clinical outcomes
9    1    1
Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection

Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection
8    1    1
Study on PET/CT findings in patients with small cell lung cancer

Study on PET/CT findings in patients with small cell lung cancer
9    109    0
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: An exploratory longitudinal study

Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: An exploratory longitudinal study
9    59    3
The result of adjuvant vinorelbine plus cisplatin in completely resected stage IB-IIIA non-small cell lung cancer at Hanoi Medical University Hospital

The result of adjuvant vinorelbine plus cisplatin in completely resected stage IB-IIIA non-small cell lung cancer at Hanoi Medical University Hospital
6    46    1
Results of concurrent chemoradiotherapy of 30 patients with inoperable stage III non-small cell lung cancer, used PET/CT planning radiation plan at 108 Military Central Hospital

Results of concurrent chemoradiotherapy of 30 patients with inoperable stage III non-small cell lung cancer, used PET/CT planning radiation plan at 108 Military Central Hospital
12    26    1
The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions

The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions
10    83    1
Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer

Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer
17    4    1
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with antiprogrammed cell death-1/ligand 1 inhibitors

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with antiprogrammed cell death-1/ligand 1 inhibitors
8    92    0
Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016
8    56    1
Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelialmesenchymal transition signature and longer survival in squamous cell lung carcinoma

Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelialmesenchymal transition signature and longer survival in squamous cell lung carcinoma
10    51    1
Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression≥50%

Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression≥50%
12    1    1
In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells

In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
10    57    1
CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9

CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9
14    79    1
Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line

Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line
12    33    1
MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD

MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD
10    89    1
LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival

LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival
9    28    1